Haemonetics (HAE) Total Debt Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Haemonetics | 3.18 Bn | 2.93 Bn | 198.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 11.59% |
| Dec 27, 2025 | 31.64% |
| Sep 27, 2025 | 21.42% |
| Jun 28, 2025 | 18.32% |
| Mar 29, 2025 | 26.21% |
| Dec 28, 2024 | 26.93% |
| Sep 28, 2024 | 26.99% |
| Jun 29, 2024 | 22.94% |
| Mar 30, 2024 | 18.20% |
| Dec 30, 2023 | 20.42% |
| Sep 30, 2023 | 17.27% |
| Jul 1, 2023 | 17.07% |
| Apr 1, 2023 | 24.73% |
| Dec 31, 2022 | 23.20% |
| Oct 1, 2022 | 23.33% |
| Jul 2, 2022 | 20.50% |
| Apr 2, 2022 | 19.71% |
| Jan 1, 2022 | 18.24% |
| Oct 2, 2021 | 15.01% |
| Jul 3, 2021 | 14.43% |
| Apr 3, 2021 | 11.64% |
| Dec 26, 2020 | -6.22% |
| Sep 26, 2020 | 1.33% |
| Jun 27, 2020 | 4.11% |
| Mar 28, 2020 | -2.22% |
| Dec 28, 2019 | -2.82% |
| Sep 28, 2019 | -2.91% |
| Jun 29, 2019 | 0.22% |
| Mar 30, 2019 | -4.37% |
| Dec 29, 2018 | -5.12% |
| Sep 29, 2018 | -5.84% |
| Jun 30, 2018 | -6.26% |
| Mar 31, 2018 | -11.98% |
| Dec 30, 2017 | -10.95% |
| Sep 30, 2017 | -9.86% |
| Jul 1, 2017 | 126.72% |
| Apr 1, 2017 | 142.26% |
| Dec 31, 2016 | 126.41% |
| Oct 1, 2016 | 127.19% |
| Jul 2, 2016 | 145.17% |
| Apr 2, 2016 | 142.36% |
| Dec 26, 2015 | 102.84% |
| Sep 26, 2015 | 93.22% |
| Jun 27, 2015 | 109.11% |
| Mar 28, 2015 | 83.58% |